福安药业（集团）

Chongqing Fuan Pharmaceutical (Group) Co Ltd (Former Chongqing Fuan Pharmaceutical Co., Ltd), established in 2004, mainly focuses on research, manufacture and sales of both APIs and formulation.In December 2014, Chongqing Fuan Pharmaceutical's second temporary general meeting of shareholders approved the bill to acquire assets by issuing shares and paying cash. The company intended to acquire 100% stock right of Ningbo Team Pharm Co Ltd by issuing 217.5 million shares at a price of RMB 18.38 (US $2.99) per share and paying RMB 170 million (US $27.68 million). The total trading amount would not exceed RMB 570 million (US $92.80 million).In February 2014, Chongqing Fuan Pharmaceutical (Group) intended to use super raise funds RMB 26.9 million (US $4.39 million) to acquire accumulative 12.38% stock right of Guangan Kate Pharmaceutical Chemical which was held by Qinghua Zhu. Fuan Pharmaceutical will hold 100% stock right of Guangan Kate after the acquisition.In August, 2014, Chongqing Fuan